Priorix-Tetra
Product details
Registration number: SIN13627P
Classification: Prescription Only
Active ingredients:
- Live attenuated measles virus (Schwarz strain)
- Live attenuated mumps virus (RIT4385 strain)
- Live attenuated rubella virus (Wistar RA 27/3 strain)
- Live attenuated varicella virus (OKA strain)
Strength:
- ≥ 10³ CCID50/dose
- ≥ 10⁴·⁴ CCID50/dose
- ≥ 10³ CCID50/dose
- ≥ 10³·³ PFU/dose
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07BD54
HSA approval date: 3 April 2009
Manufacturer(s):
- GlaxoSmithKline Biologicals s.a.
- Aspen Notre Dame de Bondeville - Diluent in syringes
- Novo Nordisk Production Belgium SA - Diluent in syringes
- FIDIA Farmaceutici S.P.A (Formulation, filling, lyophilisation)
Manufacturing country/countries: BELGIUM; FRANCE; ITALY
What are the HSA registration number and classification for Priorix-Tetra?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13627P
Classification: Prescription Only
What active ingredients and strength are recorded for Priorix-Tetra?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Live attenuated measles virus (Schwarz strain)
- Live attenuated mumps virus (RIT4385 strain)
- Live attenuated rubella virus (Wistar RA 27/3 strain)
- Live attenuated varicella virus (OKA strain)
Strength:
- ≥ 10³ CCID50/dose
- ≥ 10⁴·⁴ CCID50/dose
- ≥ 10³ CCID50/dose
- ≥ 10³·³ PFU/dose
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Priorix-Tetra?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Who is the recorded registrant for Priorix-Tetra?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for Priorix-Tetra?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GlaxoSmithKline Biologicals s.a.
- Aspen Notre Dame de Bondeville - Diluent in syringes
- Novo Nordisk Production Belgium SA - Diluent in syringes
- FIDIA Farmaceutici S.P.A (Formulation, filling, lyophilisation)
Manufacturing country/countries: BELGIUM; FRANCE; ITALY
Where can I look up Priorix-Tetra in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13627P or the exact product name Priorix-Tetra. The general register link does not preselect this product.
What are the source dates for this Priorix-Tetra record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Priorix-Tetra record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13627P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)